A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy
Clinical trial NCT03447262 · TERMINATED
Trial details
- NCT number
- NCT03447262
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2020-09-09
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.